Raymond Cheong - Net Worth and Insider Trading

Raymond Cheong Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raymond Cheong owns 2 companies in total, including Talis Biomedical Corp (TLIS) , and Madrigal Pharmaceuticals Inc (MDGL) .

Click here to see the complete history of Raymond Cheong’s form 4 insider trades.

Insider Ownership Summary of Raymond Cheong

Ticker Comapny Transaction Date Type of Owner
TLIS Talis Biomedical Corp 2023-03-10 director
MDGL Madrigal Pharmaceuticals Inc 2023-06-15 director

Raymond Cheong Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Raymond Cheong Ownership Network

Ownership Network List of Raymond Cheong

No Data

Ownership Network Relation of Raymond Cheong

Insider Network Chart

Raymond Cheong Owned Company Details

What does Talis Biomedical Corp do?

Who are the key executives at Talis Biomedical Corp?

Raymond Cheong is the director of Talis Biomedical Corp. Other key executives at Talis Biomedical Corp include President & other: Chief Scientific Officer Andrew A Lukowiak , Interim CFO Rebecca Markovich , and director & 10 percent owner Julian Baker .

Talis Biomedical Corp (TLIS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Talis Biomedical Corp (TLIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Talis Biomedical Corp (TLIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Talis Biomedical Corp (TLIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Talis Biomedical Corp Insider Transactions

No Available Data

Raymond Cheong Mailing Address

Above is the net worth, insider trading, and ownership report for Raymond Cheong. You might contact Raymond Cheong via mailing address: 860 Washington Street, 3rd Floor, New York Ny 10014.

Discussions on Raymond Cheong

No discussions yet.